MedPath

Damian Pharma AG

🇨🇭Switzerland
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:2
Completed:3

Trial Phases

2 Phases

Phase 1:3
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (60.0%)
Phase 2
2 (40.0%)

DP13 - A Phase II Study in Patients With Primary Aldosteronism

Phase 2
Completed
Conditions
Primary Aldosteronism
Interventions
First Posted Date
2019-07-05
Last Posted Date
2024-11-22
Lead Sponsor
Damian Pharma AG
Target Recruit Count
35
Registration Number
NCT04007406
Locations
🇮🇹

Ospedale Molinette, Torino, Italy

DP13 SAD & MAD in Healthy Male Subjects

Phase 1
Completed
Conditions
Safety and Tolerability
Interventions
Drug: placebo
First Posted Date
2017-02-08
Last Posted Date
2018-04-17
Lead Sponsor
Damian Pharma AG
Target Recruit Count
48
Registration Number
NCT03046589
Locations
🇬🇧

Covance Clinical Research Unit Ltd, Leeds, United Kingdom

News

No news found
© Copyright 2025. All Rights Reserved by MedPath